List of Excipients in API doxorubicin hydrochloride liposome
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing doxorubicin hydrochloride liposome
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Baxter Healthcare Corporation | DOXORUBICIN HYDROCHLORIDE LIPOSOME | doxorubicin hydrochloride liposome | 0338-0080 | AMMONIUM SULFATE | |
Baxter Healthcare Corporation | DOXORUBICIN HYDROCHLORIDE LIPOSOME | doxorubicin hydrochloride liposome | 0338-0080 | CHOLESTEROL | |
Baxter Healthcare Corporation | DOXORUBICIN HYDROCHLORIDE LIPOSOME | doxorubicin hydrochloride liposome | 0338-0080 | HISTIDINE | |
Baxter Healthcare Corporation | DOXORUBICIN HYDROCHLORIDE LIPOSOME | doxorubicin hydrochloride liposome | 0338-0080 | HYDROCHLORIC ACID | |
Baxter Healthcare Corporation | DOXORUBICIN HYDROCHLORIDE LIPOSOME | doxorubicin hydrochloride liposome | 0338-0080 | HYDROGENATED SOYBEAN LECITHIN | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for doxorubicin hydrochloride liposome
Excipient focus: AMMONIUM SULFATE
doxorubicin hydrochloride liposome drug variants containing AMMONIUM SULFATE
Company | Ingredient | NDC |
---|---|---|
Baxter Healthcare Corporation | doxorubicin hydrochloride liposome | 0338-0080 |
>Company | >Ingredient | >NDC |
doxorubicin hydrochloride liposome drug variants not containing AMMONIUM SULFATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CHOLESTEROL
doxorubicin hydrochloride liposome drug variants containing CHOLESTEROL
Company | Ingredient | NDC |
---|---|---|
Baxter Healthcare Corporation | doxorubicin hydrochloride liposome | 0338-0080 |
>Company | >Ingredient | >NDC |
doxorubicin hydrochloride liposome drug variants not containing CHOLESTEROL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HISTIDINE
doxorubicin hydrochloride liposome drug variants containing HISTIDINE
Company | Ingredient | NDC |
---|---|---|
Baxter Healthcare Corporation | doxorubicin hydrochloride liposome | 0338-0080 |
>Company | >Ingredient | >NDC |
doxorubicin hydrochloride liposome drug variants not containing HISTIDINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
doxorubicin hydrochloride liposome drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Baxter Healthcare Corporation | doxorubicin hydrochloride liposome | 0338-0080 |
>Company | >Ingredient | >NDC |
doxorubicin hydrochloride liposome drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYDROGENATED SOYBEAN LECITHIN
doxorubicin hydrochloride liposome drug variants containing HYDROGENATED SOYBEAN LECITHIN
Company | Ingredient | NDC |
---|---|---|
Baxter Healthcare Corporation | doxorubicin hydrochloride liposome | 0338-0080 |
>Company | >Ingredient | >NDC |
doxorubicin hydrochloride liposome drug variants not containing HYDROGENATED SOYBEAN LECITHIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
doxorubicin hydrochloride liposome drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Baxter Healthcare Corporation | doxorubicin hydrochloride liposome | 0338-0080 |
>Company | >Ingredient | >NDC |
doxorubicin hydrochloride liposome drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE
doxorubicin hydrochloride liposome drug variants containing SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE
Company | Ingredient | NDC |
---|---|---|
Baxter Healthcare Corporation | doxorubicin hydrochloride liposome | 0338-0080 |
>Company | >Ingredient | >NDC |
doxorubicin hydrochloride liposome drug variants not containing SODIUM N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
doxorubicin hydrochloride liposome drug variants containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
Baxter Healthcare Corporation | doxorubicin hydrochloride liposome | 0338-0080 |
>Company | >Ingredient | >NDC |
doxorubicin hydrochloride liposome drug variants not containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.